SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-583840
Filing Date
2016-05-09
Accepted
2016-05-09 16:15:26
Documents
39
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d177079d10q.htm 10-Q 504373
2 EX-31.1 d177079dex311.htm EX-31.1 6130
3 EX-31.2 d177079dex312.htm EX-31.2 5867
4 EX-32.1 d177079dex321.htm EX-32.1 4176
  Complete submission text file 0001193125-16-583840.txt   1811698

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT drna-20160331.xml EX-101.INS 230436
6 XBRL TAXONOMY EXTENSION SCHEMA drna-20160331.xsd EX-101.SCH 21947
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE drna-20160331_cal.xml EX-101.CAL 32505
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE drna-20160331_def.xml EX-101.DEF 60460
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE drna-20160331_lab.xml EX-101.LAB 174905
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drna-20160331_pre.xml EX-101.PRE 119427
Mailing Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36281 | Film No.: 161631833
SIC: 2834 Pharmaceutical Preparations